IMMUNOGL. SNAKE ANTIVENOM, Africa (EchiTab-Plus) 10ml, vial

NST DVACIMAS2V-

Valid Article

Former Code(s): DVACZFR0103
The product is supplied (and stored) sterile, it must remain sterile until its use. Sterile = state of being free from all living microorganisms.
19.2 - Sera, immunoglobulins and monoclonal antibodies
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
J06AA03
Anatomical Therapeutic Chemical Classification according to WHOCC
The order of this product needs to be justified and is only acceptable under certain conditions.
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

See Related

Add article to list

   

Add Kit To Wishlist

   

IMMUNOGLOBULIN SNAKE ANTIVENOM, Africa (EchiTab-Plus)

This product is not always available at supply centres level. Contact your HQ advisor and check the specifications if an alternative is offered.

Full Name

EchiTAb-plus-ICP, Polyspecific Antivenom Liquid

Therapeutic Action

Neutralisation of snake venom

Equine serum globulins

Indications

Treatment of snakebite envenomations from 22 African species found in sub-Saharan Africa, including:

  • West African carpet viper (Echis ocellatus)
  • Puff adder (Bitis‌ arietans)
  • Black-necked spitting cobra (Naja nigricollis)
Some restricted information has been hidden. Sign in to see this information

Instructions for use

10 ml vial in liquid form

Must be given as IM injection or IV infusion (after dilution in 0.9% NaCl).

The minimum dose in case of envenomation is 4 vials.

Read the manufacturer's instructions.

Precautions for Use

Appropriate medical treatment should always be readily available in case of anaphylactic reactions following the administration of the product.

Storage

  • Keep refrigerated between 2ºC and 8ºC.
  • Do not freeze.
  • After opening, use the product immediately.

(Cf Introduction: Thermosensitive products)